OTCM
RPNRF
Market cap2.77bUSD
Jul 31, Last price
10,000.00USD
1D
0.00%
1Q
0.00%
IPO
19,999,900.00%
Name
Rapid Nutrition PLC
Chart & performance
P/E
—
P/S
39,103,230.08
EPS
—
Div yield, %
—
Shrs. gr., 5y
-61.97%
Rev. gr., 5y
-39.71%
Revenues
195k
-78.70%
Net income
-3m
L+7.36%
CFO
-3m
L+4.90%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rapid Nutrition PLC is a natural healthcare enterprise that researches, develops, and manufactures a diverse portfolio of science-backed health and wellness products. Its market presence extends across the United Kingdom, Australia, Asia, the United States, and other international regions. The company offers a range of organic and natural, scientifically formulated health food supplements, primarily distributed under the SystemLS and Leisa's Secret trademarks. Furthermore, it produces oral antiviral therapeutic solutions, marketed as Azurene, aimed at combating influenza and the common cold. The company was established in 2001 and is headquartered in London, UK.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||